Download PDF
Thromb Haemost 1990; 64(03): 486
DOI: 10.1055/s-0038-1647342
Letter to the Editor
Schattauer GmbH Stuttgart

How Much Aspirin?

J R O’Brien
The Haematology Research Laboratories St. Mary’s Hospital Portsmouth, Hants., PO3 6AG, U. K.
,
M D Ethwrington
The Haematology Research Laboratories St. Mary’s Hospital Portsmouth, Hants., PO3 6AG, U. K.
› Author Affiliations
Further Information

Publication History

Received 06 April 1990

Accepted after revision 25 June 1990

Publication Date:
25 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Antiplatelet Tiialists Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 1988 296. 316-319
    PubMedGoogle Scholar
  • 2 Reilly IA G, Fitzgerald GA. Inhibition of Thromboxane formation in vivo and ex vivo: implication for therapy with platelet inhibitory drugs.. Blood 1987; 69: 180-186
    PubMedGoogle Scholar
  • 3 Toivanen J, Ylikorkala O, Viinikka L. One milligramme of acetylsalicylic acid daily inhibits platelet thromboxane A2 production. Thromb Res 1984; 35: 681-687
    CrossrefPubMedGoogle Scholar